Portfolio company
Cellevate
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops nanofiber cell culture microcarriers for biopharmaceutical manufacturers to enhance viral vaccine and gene therapy production yields.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Lentitek
This company develops manufacturing technologies for lentiviral vectors to help cell and gene therapy developers improve the production of advanced cancer treatments.
CellFE
The company develops microfluidic platforms for intracellular delivery of molecules to support cell therapy developers and researchers in manufacturing engineered cells.
Scinus Group
This company develops automated, closed bioreactor systems for large-scale cell expansion, serving the cell therapy and regenerative medicine industries.
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
VIVOLTA
This company develops and manufactures electrospun medical products, such as implants and drug delivery solutions, for medical device and pharmaceutical companies.
Biothrust
This company develops bionic bioreactors for bubble-free cell cultivation to enable scalable manufacturing for pharmaceutical firms, research institutions and therapy developers.
Cellular Agriculture
The company develops hollow fibre bioreactor technology for industrial-scale production of cultivated food and biopharmaceuticals for food manufacturers and life sciences organisations.
BlueWhale Bio
This company develops cell-derived nanoparticle technology to activate and expand immune cells for cell therapy manufacturers and clinical researchers.
